{"company":{"id":2540320,"name":"OverT Bio","domain":"overt.bio","url":"https://alion.io/company/overt-bio"},"section":"news","answer":"OverT Bio: 15 headlines on record, 0 headlines in the last 90 days. Its story counts 2 milestones.","figures":[{"label":"Headlines","value":"15"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"2"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":12},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":2}],"news":[{"date":"2026-08-17","kind":"Press release","title":"/C O R R E C T I O N -- The Galien Foundation/","source":"PRNewswire","url":"https://prnewswire.com/news-releases/the-galien-foundation-announces-2026-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-302850770.html?tc=eml_cleartime"},{"date":"2026-03-24","kind":"News","title":"Overt Bio advances OVT-101 toward clinic","source":"bioworld.com","url":"https://bioworld.com/articles/729861-overt-bio-advances-ovt-101-toward-clinic?v=preview"},{"date":"2026-03-23","kind":"Press release","title":"OverT Bio Announces the Formation of the Clinical Advisory Board to Support the Clinical Development of OVT-101 in Ovarian Cancer and Other Solid Tumors","source":"businesswire.com","url":"https://businesswire.com/news/home/20260323533873/en/OverT-Bio-Announces-the-Formation-of-the-Clinical-Advisory-Board-to-Support-the-Clinical-Development-of-OVT-101-in-Ovarian-Cancer-and-Other-Solid-Tumors"},{"date":"2025-02-13","kind":"News","title":"Grow Without Limits","source":"jpmorgan.com","url":"https://jpmorgan.com/commercial-banking/startups/grow-without-limits-lp"},{"date":"2024-11-22","kind":"Press release","title":"OverT Bio Receives $120K G-Rex(R) Grant to Propel Solid Tumor Cell Therapy Advancements","source":"marketwatch.com","url":"https://marketwatch.com/press-release/overt-bio-receives-120k-g-rex-r-grant-to-propel-solid-tumor-cell-therapy-advancements-a17b390c"},{"date":"2024-10-09","kind":"News","title":"Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors","source":"taiwannews.com.tw","url":"https://taiwannews.com.tw/news/5949683"},{"date":"2024-05-16","kind":"News","title":"OverT Bio: $16 Million Raised To Unlock The Potential Of Cell Therapies In Solid Tumors","source":"Pulse 2.0","url":"https://pulse2.com/overt-bio-16-million-raised-to-unlock-the-potential-of-cell-therapies-in-solid-tumors/"},{"date":"2024-05-11","kind":"News","title":"OverT Bio获得1600万美元种子轮融资- DoNews快讯","source":"donews.com","url":"https://donews.com/news/detail/8/4224897.html"},{"date":"2024-05-06","kind":"News","title":"PRN_FinancialWrapper","source":"PRNewswire","url":"https://markets.financialcontent.com/prnews.pressrelease/article/bizwire-2024-5-6-overt-bio-raises-16-million-tapping-innovative-reprogramming-of-immune-cells-to-deliver-next-generation-therapies"},{"date":"2024-05-06","kind":"News","title":"New York biotech debuts with 16M to find new ways to make solid cancer cell therapies May 6, 2024","source":"endpoints.news","url":"https://endpoints.news/overt-bio-debuts-with-16m-to-find-new-ways-to-make-solid-cancer-cell-therapies/"},{"date":"2024-05-05","kind":"Press release","title":"OverT Bio Raises $16 Million, Tapping Innovative Reprogramming of Immune Cells to Deliver Next-Generation Therapies","source":"businesswire.com","url":"https://businesswire.com/news/home/20240506288516/en/OverT-Bio-Raises-$16-Million-Tapping-Innovative-Reprogramming-of-Immune-Cells-to-Deliver-Next-Generation-Therapies"},{"date":"2023-11-22","kind":"Press release","title":"OverT Bio Receives 120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements November 22, 2023","source":"businesswire.com","url":"https://businesswire.com/news/home/20241122444716/en/OverT-Bio-Receives-%24120K-G-Rex-Grant-to-Propel-Solid-Tumor-Cell-Therapy-Advancements"}],"story":[{"title":"Raised a round Venture round $16M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1973901/000197390123000001/"},{"title":"Founded"}],"as_of":"2026-11-17","cite":"OverT Bio, News. Alion, Nov 17, 2026. https://alion.io/company/overt-bio/news","html_url":"https://alion.io/company/overt-bio/news","json_url":"https://alion.io/company/overt-bio/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T10:47:45Z"}}